Silke Polata

465 total citations
4 papers, 46 citations indexed

About

Silke Polata is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Silke Polata has authored 4 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Silke Polata's work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). Silke Polata is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). Silke Polata collaborates with scholars based in Germany, Austria and Switzerland. Silke Polata's co-authors include David Krug, Toralf Reimer, Michael Golatta, Sibylle Loibl, Dirk-Michael Zahm, Jörg Heil, Marc Thill, Guido Hildebrandt, Michael Knauer and Bernd Gerber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Silke Polata

4 papers receiving 46 citations

Peers

Silke Polata
Comparison fields: 5 of 12
  • Cancer Research 41
  • Pathology and Forensic Medicine 27
  • Surgery 20
  • Oncology 20
  • Pulmonary and Respiratory Medicine 6
Replace Daiva Čepulienė with:
Daiva Čepulienė Lithuania
Magali Le Blanc‐Onfroy France
S Timbrell United Kingdom
J.L. Gago Ramos Spain
Matilda Appelgren Sweden
Marie Osdoit France
Jan Žatecký Czechia
Paolo Delrio Italy
Mathilde Ritter Switzerland
Amtul Sami United Kingdom
Daiva Čepulienė Lithuania View profile →
Citations per field, relative to Silke Polata
Silke Polata · 1×
Citations per year, relative to Silke Polata
Silke Polata · 1×

Countries citing papers authored by Silke Polata

Since Specialization
Citations

This map shows the geographic impact of Silke Polata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Polata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Polata more than expected).

Fields of papers citing papers by Silke Polata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Polata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Polata. The network helps show where Silke Polata may publish in the future.

Co-authorship network of co-authors of Silke Polata

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Polata. A scholar is included among the top collaborators of Silke Polata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Polata. Silke Polata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
# Work Indexed citations
1 2
2 1
3 39
4 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026